Comments
Loading...

Analyst Ratings

INMD
Logo brought to you by Benzinga Data
Consensus Rating1
Hold
Highest Price Target1
$61.00
Lowest Price Target1
$16.00
Consensus Price Target1
$28.29

Analyst Ratings and Price Targets | :INMD | Benzinga

has a consensus price target of $28.29 based on the ratings of 8 analysts. The high is $61 issued by Baird on July 28, 2023. The low is $16 issued by Canaccord Genuity on July 12, 2024. The 3 most-recent analyst ratings were released by Barclays, Barclays, and BTIG on February 5, 2025, January 9, 2025, and October 17, 2024, respectively. With an average price target of $26.67 between Barclays, Barclays, and BTIG, there's an implied 42.22% upside for from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Oct 24
1
Jan
1
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Barclays
BTIG
Jefferies
Canaccord Genuity
UBS

1calculated from analyst ratings

Analyst Ratings for

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for (INMD) stock?

A

The latest price target for (:INMD) was reported by Barclays on February 5, 2025. The analyst firm set a price target for $29.00 expecting INMD to rise to within 12 months (a possible 54.67% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for (INMD)?

A

The latest analyst rating for (:INMD) was provided by Barclays, and maintained their overweight rating.

Q

When was the last upgrade for (INMD)?

A

There is no last upgrade for

Q

When was the last downgrade for (INMD)?

A

The last downgrade for happened on July 23, 2024 when Jefferies changed their price target from $21 to $19 for .

Q

When is the next analyst rating going to be posted or updated for (INMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of , and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for was filed on February 5, 2025 so you should expect the next rating to be made available sometime around February 5, 2026.

Q

Is the Analyst Rating (INMD) correct?

A

While ratings are subjective and will change, the latest (INMD) rating was a maintained with a price target of $26.00 to $29.00. The current price (INMD) is trading at is $18.75, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.